Schedule 13G ownership disclosure

Alto Neuroscience Inc

Common Stock, $0.0001 par value per share · CUSIP: 02157Q109

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • K2 HealthVentures Equity Trust LLC

    Shares: 788,995 · Class: 2.4%

  • Parag Shah

    Shares: 788,995 · Class: 2.4%

  • Anup Arora

    Shares: 788,995 · Class: 2.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905148-26-000894
Form type
SCHEDULE 13G/A
Filer
Alto Neuroscience, Inc.
CIK
CIK 1999480
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub